Dynavax(DVAX) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs EMERYVILLE, CA – May 6, 2025 – Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a business update for the quarter ended March 31, 2025. "We started 2025 off strong, executing across our strategic growth initiatives, including delivering our highest first quarter net ...